These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36418865)

  • 1. The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer.
    Su YT; Chen JW; Chang SC; Jiang JK; Huang SC
    Sci Rep; 2022 Nov; 12(1):20075. PubMed ID: 36418865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of Discordance between Carcinoembryonic Antigen Levels and RECIST in Metastatic Colorectal Cancer.
    Kim IH; Lee JE; Yang JH; Jeong JW; Ro S; Oh ST; Kim JG; Choi MH; Lee MA
    Cancer Res Treat; 2018 Jan; 50(1):283-292. PubMed ID: 28494536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of Carcinoembryonic Antigen Ratio and Response Evaluation Criteria in Solid Tumors as Prognostic Surrogate Indicators of Metastatic Colorectal Cancer Patients Treated with Chemotherapy.
    Huang SC; Lin JK; Lin TC; Chen WS; Yang SH; Wang HS; Lan YT; Lin CC; Jiang JK; Chang SC
    Ann Surg Oncol; 2015 Jul; 22(7):2262-8. PubMed ID: 25586242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an Algorithm to Predict Recurrences After Resection of Liver Metastases in Patients With Metastatic Colorectal Cancer.
    Katagiri M; Sudo T; Tounann T; Kakuma T; Shimomura S; Nagasu S; Tajiri K; Fujino S; Yuge K; Murakami H; Miwa K; Hisaka T; Fujita F; Akagi Y
    Anticancer Res; 2023 Aug; 43(8):3807-3816. PubMed ID: 37500151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response.
    Kim IH; Lee JE; Yang JH; Jeong JW; Ro S; Lee MA
    Asia Pac J Clin Oncol; 2018 Jun; 14(3):239-246. PubMed ID: 29044941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic Antigen-related Tumor Kinetics After Eight Weeks of Chemotherapy is Independently Associated With Overall Survival in Patients With Metastatic Colorectal Cancer.
    Colloca GA; Venturino A; Guarneri D
    Clin Colorectal Cancer; 2020 Dec; 19(4):e200-e207. PubMed ID: 32952072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
    Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen kinetics predict response to first-line treatment in metastatic colorectal cancer: Analysis from PRODIGE 9 trial.
    Salfati D; Huot M; Aparicio T; Lepage C; Taieb J; Bouché O; Boige V; Phelip JM; Dahan L; Bennouna J; Le Malicot K; Boussari O; Gornet JM
    Dig Liver Dis; 2023 Jun; 55(6):791-798. PubMed ID: 36725401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Threshold Change in CEA as a Predictor of Non-Progression to First-Line Systemic Therapy in Metastatic Colorectal Cancer Patients With Elevated CEA.
    Gulhati P; Yin J; Pederson L; Schmoll HJ; Hoff P; Douillard JY; Hecht JR; Tournigand C; Tebbut N; Chibaudel B; Gramont A; Shi Q; Overman MJ
    J Natl Cancer Inst; 2020 Nov; 112(11):1127-1136. PubMed ID: 32191317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of endoscopic tattooing with carbon nanoparticlet in the treatment for advanced colorectal cancer].
    Wang R; Zhan HL; Li DZ; Li HT; Yu L; Wang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):56-64. PubMed ID: 31958932
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor markers CEA and CA 19-9 correlate with radiological imaging in metastatic colorectal cancer patients receiving first-line chemotherapy.
    Michl M; Koch J; Laubender RP; Modest DP; Giessen C; Schulz Ch; Heinemann V
    Tumour Biol; 2014 Oct; 35(10):10121-7. PubMed ID: 25023402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can carcinoembryonic antigen replace computed tomography in response evaluation of metastatic colorectal cancer?
    Hermunen K; Lantto E; Poussa T; Haglund C; Österlund P
    Acta Oncol; 2018 Jun; 57(6):750-758. PubMed ID: 29388498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of carcinoembryonic antigen distribution in tumor tissue of colorectal carcinoma.
    Nazato DM; Matos LL; Waisberg DR; Souza JR; Martins LC; Waisberg J
    Arq Gastroenterol; 2009; 46(1):26-31. PubMed ID: 19466306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer?
    Selcukbiricik F; Bilici A; Tural D; Erdamar S; Soyluk O; Buyukunal E; Demirelli F; Serdengecti S
    Tumour Biol; 2013 Aug; 34(4):2233-9. PubMed ID: 23625655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer.
    Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Fan FS; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
    Int J Colorectal Dis; 2001 Apr; 16(2):96-101. PubMed ID: 11355325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative CEA values in metastatic colorectal carcinoma and the likelihood of complete chemotherapy response.
    Tomasevic Z; Jelic S; Nikolic L; Filipovic I; Stamatovic L; Radosavljevic D
    Int J Biol Markers; 2003; 18(1):28-32. PubMed ID: 12699060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
    He WZ; Guo GF; Yin CX; Jiang C; Wang F; Qiu HJ; Chen XX; Rong RM; Zhang B; Xia LP
    Colorectal Dis; 2013 Aug; 15(8):e443-52. PubMed ID: 23621885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
    Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
    World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is circulating D-dimer level a better prognostic indicator than CEA in resectable colorectal cancer? Our experience on 199 cases.
    Pedrazzani C; Cerullo G; Marrelli D; Fernandes E; Carlucci F; Corso G; Bettarini F; De Stefano A; Roviello F
    Int J Biol Markers; 2010; 25(3):171-6. PubMed ID: 20878623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.